The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 12,720.6 million in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
GLP-1 receptor agonists are a class of medications used in the treatment of type 2 diabetes. They work by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that stimulates insulin ... Read more
